Bioorganic and Medicinal Chemistry Letters p. 907 - 912 (1997)
Update date:2022-08-04
Topics:
Astles, Peter C.
Brown, Thomas J.
Cox, Paul
Halley, Frank
Lockey, Peter M.
McCarthy, Clive
McLay, Iain M.
Majid, Tahir N.
Morley, Andrew D.
Porter, Barry
Ratcliffe, Andrew J.
Walsh, Roger J.A.
A series of phenylguanidines which bind to the C5a receptor has been developed. The lead compound 1 (IC50 = 30 μM), discovered through random screening, has been modified to provide 32 (RPR121154) with submicromolar activity. This compound was
View MoreSuzhou SuKaiLu Chemical Technology Co., Ltd.
Contact:+86-512-62766020
Address:Floor 4, Building 1, Xinyi Pharmaceutical Valley Wisdom Industrial Park, 415 Changyang Street, Suzhou Industrial Park, Jiangsu Province
Shijiazhuang Haotian Chemical Co., Ltd.
Contact:86-311-85044374
Address:293 Donggang Road
Wuhan Soleado Technology Co.,Ltd.
Contact:86-2783341481 18971291927
Address:RM2405 Unit 1 Builing 1, Taiyin Tower, Changqing Road,Wuhan China
Mollt Biochem Co., Ltd(expird)
Contact:+86-21-38682181
Address:shanghai ,china
website:http://www.shochem.com
Contact:021-50800795
Address:No.1043, Halei Rd, Zhangjiang Hi-Tech Park, Shanghai, Postcode 201203, China
Doi:10.3184/174751912X13383107316656
(2012)Doi:10.1016/j.ejmech.2013.05.035
(2013)Doi:10.1002/ejic.201201427
(2013)Doi:10.1039/c39920001247
(1992)Doi:10.1055/s-0032-1316899
(2013)Doi:10.1021/ja972099o
(1997)
